In a historic move to combat cervical cancer, the Federal Government has integrated the Human Papillomavirus (HPV) vaccine into the routine immunization system, aiming to safeguard the health of millions of young girls.
This pivotal vaccination initiative is set to impact over seven million girls, marking the largest-ever round of HPV vaccination in the African region. The vaccine, administered as a single dose, offers protection against HPV types 16 and 18, which are responsible for at least 70 percent of cervical cancers.
Cervical cancer stands as the third most prevalent cancer in Nigeria and the second leading cause of cancer-related deaths among women aged 15 to 44. In 2020, the country witnessed a staggering 12,000 new cases and 8,000 fatalities due to this relentless disease.
As part of the launch, a five-day mass vaccination campaign will be carried out within schools and communities in 16 states and the Federal Capital Territory, as outlined in a statement by the World Health Organization. Subsequently, the vaccine will be incorporated into routine immunization schedules at healthcare facilities. The second phase of this groundbreaking vaccination introduction is scheduled to commence in May 2024, encompassing 21 states.
The vaccine is provided at no cost, made possible through the Federal Ministry of Health in collaboration with the National Primary Health Care Development Agency, with crucial support from Gavi, the Vaccine Alliance, the United Nations Children’s Fund (UNICEF), the World Health Organization, and other vital partners. To ensure the success of this ambitious endeavor, a dedicated team of over 35,000 healthcare workers has been meticulously trained.
Vaccination sites have been established in all 4,163 wards spanning the 16 states involved in the first phase rollout, a strategic measure to leave no eligible girl behind in the campaign against cervical cancer. This comprehensive approach not only holds the promise of protecting countless lives but also reflects Nigeria’s commitment to women’s health and the welfare of its citizens.
Understanding Human Papillomavirus (HPV) and Its… Human Papilloma Virus (HPV) is a significant public health concern among young girls in Nigeria. The rising cases of HPV infection and cervical cancer in the country are alarming, highlighting the urgent need for awareness,…
NPHCDA Raises Alarm Over Low Adoption of Cervical… Lagos State registers concerning vaccine hesitancy, hindering the fight against the second most prevalent cancer among women aged 15 to 44. In a worrisome development, the National Primary Healthcare Development Agency (NPHCDA) has expressed deep…
Enugu State Achieves Milestone: 220,000 Girls… Enugu State has made significant strides in public health by successfully vaccinating 220,000 girls against the Human Papillomavirus (HPV) to prevent cervical cancer. The groundbreaking initiative, conducted by the Enugu State Primary Health Care Development…
Adamawa State Aims to Safeguard 388,180 Girls from… The Adamawa State Primary Healthcare Development Agency has embarked on a vital mission to vaccinate 388,180 girls aged nine to 14 against the Human Papilloma Virus (HPV). The overarching goal of this initiative is to…
